TODAY’S TRADEMARK – MABXIENCE

The trademark MABXIENCE, owned by MABXIENCE RESEARCH, S.L., was registered in USPTO bearing registration number 5472348 on May 22, 2018.

Mabxience is a pharmaceutical company dedicated to the development and production of innovative pharmaceutical preparations for the treatment of a wide range of diseases and disorders. With a focus on addressing critical medical needs, Mabxience’s products target various therapeutic areas, including ophthalmology, dermatology, gastroenterology, gynecology, oncology, cardiology, neurology, psychiatry, and more.

In addition to pharmaceuticals, Mabxience manufactures dietetic foods adapted for medical use, including breads, pastas, nutritional bars, and food supplements in various forms to support the dietary needs of individuals with specific medical conditions.

In the realm of ophthalmology, Mabxience offers pharmaceutical preparations tailored to treat diseases and disorders affecting the eyes, such as glaucoma and other ophthalmic conditions. These medications aim to improve vision and alleviate symptoms associated with ocular diseases.